What was checked
Russia has successfully tested a cancer vaccine. First patient (stage-three melanoma) shows no signs of new tumors four months after personalized mRNA treatment
Assessment summary
Needs cautionRussia has reported an initial positive result for a personalized mRNA treatment, but available reporting describes a single early case and says the findings have not been independently verified.